Neutral lipid storage disease (Q40063): Difference between revisions

@@ description / pt-br / description / pt-br @@
+Doença de depósito de lipídios neutros refere-se a um grupo de doenças caracterizadas por uma deficiência na degradação dos triglicerídeos citoplasmáticos e seu acúmulo em vacúolos lipídicos citoplasmáticos na maioria dos tecidos do corpo. O grupo é heterogêneo: Doença de depósito de lipídios neutros com ictiose (doença de Dorfman-Chanarin) e com miopatia (miopatia de depósito de lipídios neutros) podem ser distinguidos.
@@ description / en / description / en @@
+Neutral lipid storage disease (NLSD) refers to a group of diseases characterised by a deficit in the degradation of cytoplasmic triglycerides and their accumulation in cytoplasmic lipid vacuoles in most tissues of the body. The group is heterogeneous: NLSD with ichthyosis (NLSDI/Dorfman-Chanarin disease) and NLSD with myopathy (NLSDM/neutral lipid storage myopathy) can be distinguished.
@@ Property / Canonical URI @@
+https://id.who.int/icd/entity/621440298
@@ Property / Canonical URI: https://id.who.int/icd/entity/621440298 / rank @@
+Normal rank
@@ Property / CURIE @@
+CID11:5C52.2
@@ Property / CURIE: CID11:5C52.2 / rank @@
+Normal rank
@@ Property / Canary Token @@
+dki-india-5C52.2
@@ Property / Canary Token: dki-india-5C52.2 / rank @@
+Normal rank
@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-13T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-13T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 13 August 2026 / rank @@
+Normal rank
@@ Property / Linked ICD 10 @@
+E75
@@ Property / Linked ICD 10: E75 / rank @@
+Normal rank

Latest revision as of 05:43, 13 August 2026

Neutral lipid storage disease (NLSD) refers to a group of diseases characterised by a deficit in the degradation of cytoplasmic triglycerides and their accumulation in cytoplasmic lipid vacuoles in most tissues of the body. The group is heterogeneous: NLSD with ichthyosis (NLSDI/Dorfman-Chanarin disease) and NLSD with myopathy (NLSDM/neutral lipid storage myopathy) can be distinguished.

Language	Label	Description	Also known as
default for all languages	5C52.2
English	Neutral lipid storage disease	Neutral lipid storage disease (NLSD) refers to a group of diseases characterised by a deficit in the degradation of cytoplasmic triglycerides and their accumulation in cytoplasmic lipid vacuoles in most tissues of the body. The group is heterogeneous: NLSD with ichthyosis (NLSDI/Dorfman-Chanarin disease) and NLSD with myopathy (NLSDM/neutral lipid storage myopathy) can be distinguished.